Aratana Therapeutics is classified as operating in the Veterinary Services industry, NAICS Code 54194.
Aratana Therapeutics is a publicly traded company on NGM using the ticker symbol PETX.
Detailed information on company financials and operating reports can be found here:
NGM: PETX
Aratana Therapeutics Annual Revenue and Growth Rate
Note: Aratana Therapeutics's revenues are gauged from an analysis of company filings.
Investor Activity
Aratana Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.
Date
Investors
Percent Raised
Target Size
October 23, 2013
17
100%
$30 MM
Complete list of funding rounds and total amounts in the Company Report
Trademark Applications
Trademark applications show the products and services that Aratana Therapeutics is developing and marketing.
Aratana Therapeutics doesn't have any recent trademark applications, indicating Aratana Therapeutics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
ELURA Veterinary pharmaceutical preparations for management of weight loss in domestic animals
03/03/2017
BLONTRESS veterinary pharmaceutical preparations for the treatment of cancer and B-cell mediated diseases in dogs
05/05/2015
GALLIPRANT veterinary pharmaceutical preparations for the treatment of osteoarthritis in horses
03/28/2014
See all trademarks and details in the Full Report.
Market Share of Aratana Therapeutics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Aratana Therapeutics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Aratana Therapeutics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Aratana Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.